Diego Cadavid is listed as an executive officer on 2 SEC Form D filings by 2 issuers between Jun 2020 and Jul 2022: X4 Pharmaceuticals, Inc (Boston, MA — biotechnology — 2022; $85M reported sold to 23 investors) and Fulcrum Therapeutics, Inc. (Cambridge, MA — biotechnology — 2020; $80M reported sold to 20 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 2 years. Across those companies the filings report $165M sold in total.
Listed alongside Adam S. Mostafa (1 shared filing), Alan Ezekowitz (1 shared filing), Alison Lawton (1 shared filing), Arthur Taveras (1 shared filing), BRYAN STUART (1 shared filing) and 16 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Diego. Each name links to their own page.
1 of the issuers belongs to the sponsor group X4 Pharmaceuticals (2 issuers, $120M reported sold, 2010–2025).
What this means A sponsor group is one team that sets up a new company for each deal. X4 Pharmaceuticals has 2 companies on file and $120M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.
What this means 10 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Diego Cadavid and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.